Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01686711
What this trial is testing

A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322

Who this might be right for
Diabetes Mellitus
Takeda 207
Large-scale testing (Phase 3)Study completedNCT00509236
What this trial is testing

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)

Who this might be right for
Diabetes Mellitus, Type 2End-Stage Kidney Disease
Merck Sharp & Dohme LLC 129
Large-scale testing (Phase 3)Study completedNCT01505426
What this trial is testing

Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients

Who this might be right for
Type II Diabetes Mellitus
Astellas Pharma Inc 171
Large-scale testing (Phase 3)Looking for participantsNCT07743983
What this trial is testing

BGM0504 in Early T2DM With Obesity

Who this might be right for
Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd. 372
Large-scale testing (Phase 3)Study completedNCT00643851
What this trial is testing

An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets

Who this might be right for
Type 2 Diabetes
AstraZeneca 994
Large-scale testing (Phase 3)UnknownNCT01257334
What this trial is testing

Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea

Who this might be right for
Type 2 Diabetes
Taipei Medical University WanFang Hospital 1,390
Large-scale testing (Phase 3)Study completedNCT01225081
What this trial is testing

Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 152
Post-approval studies (Phase 4)UnknownNCT00699322
What this trial is testing

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

Who this might be right for
Type 2 Diabetes
The Catholic University of Korea 36
Large-scale testing (Phase 3)Study completedNCT04233801
What this trial is testing

Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 219
Large-scale testing (Phase 3)Study completedNCT01204294
What this trial is testing

Comprehensive Add on Study in Japan

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 574
Testing effectiveness (Phase 2)Active Not RecruitingNCT07055386
What this trial is testing

Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 90
Large-scale testing (Phase 3)Study completedNCT01814748
What this trial is testing

The Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)

Who this might be right for
Diabetes Mellitus
Merck Sharp & Dohme LLC 203
Post-approval studies (Phase 4)Study completedNCT03770052
What this trial is testing

Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie

Who this might be right for
Type 2 Diabetes MellitusInadequate Glucose Control
Pusan National University Hospital 159
Large-scale testing (Phase 3)Study completedNCT01778049
What this trial is testing

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 708
Large-scale testing (Phase 3)Active Not RecruitingNCT06290349
What this trial is testing

Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes
Dong-A ST Co., Ltd. 174
Large-scale testing (Phase 3)Study completedNCT02897349
What this trial is testing

Linagliptin Add-on to Insulin Background Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 206
Large-scale testing (Phase 3)Study completedNCT01242215
What this trial is testing

Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 243
Large-scale testing (Phase 3)Study completedNCT00660907
What this trial is testing

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,217
Large-scale testing (Phase 3)Study completedNCT01164501
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Boehringer Ingelheim 741
Post-approval studies (Phase 4)Study completedNCT03202563
What this trial is testing

Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)

Who this might be right for
Type 2 Diabetes Mellitus
LG Chem 71
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation